Latest Daily News

Latest News
June 4, 2017

In view of these findings, investigators in the IDEA collaboration reached a clinical consensus to recommend a risk-based approach to selecting adjuvant chemotherapy for stage III colon cancer. 

Read more

June 4, 2017

The BILCAP randomized study examined a cancer type for which “outcomes are poor—the 1- and 5-year survival rates are 22% and 9%, respectively,” said presenter Dr. John N. Primrose.

Read more
June 2, 2017

Here are some bite-sized articles from Saturday's ASCO Daily News coverage.

Read more
May 25, 2017

The Extended Education Session “Management of Complex Upper Gastrointestinal Cases: Implementation of Best Evidence,” to be held on June 2, will address these and other questions facing oncologists specializing in upper GI cancers.

Read more
May 25, 2017

The guideline, organized into 21 recommendations of how to use molecular biomarkers to diagnose and treat patients with colorectal cancer, represented an unprecedented collaboration between four organizations: CAP, ASCP, the Association for Molecular Pathology, and ASCO.

Read more
May 25, 2017

Patients with potentially curable pancreatic cancer should be treated with two medications—gemcitabine and capecitabine—after tumor resection, as long as there are no concerns about toxicity and chemotherapy.

Read more
April 7, 2017

The 2017 Gastrointestinal Cancers Symposium concluded another year of enlightening discourse, multidisciplinary education, and fruitful interaction among the more than 3,500 attendees.

Read more
June 6, 2016

Results from the FAST study demonstrated that IMAB362, an antibody against claudin, a tight junction protein, significantly prolonged median PFS and OS in gastric cancers. 

Read more
June 6, 2016

CRITICS reports on which adjuvant strategy, chemotherapy or chemoradiotherapy, provides better clinical outcomes for patients with resectable gastric cancer. What’s next for these patients? 

Read more

June 7, 2016

Phase III trial CALGB 80802 failed to demonstrate OS benefit with addition of doxorubicin to sorafenib in the first-line treatment of advanced HCC. The results contradict earlier phase II data, and suggest that the role of chemotherapy in advanced HCC could come to an end.

Read more

June 7, 2016

The benefits of palliative care for patients with advanced cancer and short life expectancy has been well established. New research suggests this care could improve quality of life and mood both among patients with lung and GI cancers early in the course of disease and their caregivers.

Read more
June 7, 2016

This Education Session offers insight into how past failures in gastric cancer, along with emerging genetic and molecular information, hold good solutions to solving the current treatment conundrum for this disease.

Read more
May 26, 2016

The Fibrolamellar-Hepatocellular Carcinoma Consortium brings together multiple academic medical centers and universities to cooperate and share information about FL-HCC. 

Read more

May 26, 2016

Drs. Cinar and Picozzi summarize the history of pancreatic cancer treatment options, the challenges associated with treatment and recurrence prevention, and the emerging adjuvant options being studied in current ongoing trials.

Read more

May 26, 2016

Jack Andraka, who at age 15 developed an inexpensive blood test for pancreatic cancer, reflects on his work in cancer.

Read more

May 26, 2016

ASCO’s Clinical Practice Guidelines Committee initiated a Pancreatic Cancer Working Group in 2015 to help standardize the care of people with pancreatic cancer.

Read more

May 26, 2016

Recent progress has been made in understanding the biology behind esophagogastric cancer, and as a result, several targeted strategies have been developed or are under development.

Read more
May 29, 2015

 Immunotherapeutic strategies for the treatment of gastric cancer, the fourth most common cause of cancer-related death, are drawing increased interest among physicians and researchers.

Read more

May 29, 2015

Colorectal cancer incidence is increasing in resource-constrained countries among young adults, which could be linked to environmental pollution or lifestyle factors such as obesity, physical inactivity, and a diet rich in processed foods.

Read more
May 30, 2015

RAS mutation analysis should be ordered on all patients with newly diagnosed metastatic colorectal cancer. The goals of therapy should be identified early, including whether the tumor is resectable or borderline resectable, or whether palliative treatment is indicated. 

Read more